key: cord-0746281-9dm5j6gc
authors: Gunadi,; Hakim, M. S.; Wibawa, H.; Vujira, K.; Puspitarani, D. A.; Supriyati, E.; Trisnawati, I.; Iskandar, K.; Khair, R. E.; Afiahayati,; Siswanto,; Puspadewi, Y.; Irene,; Irianingsih, S. H.; Daniwijaya, E. W.; Nugrahaningsih, D. A. A.; Gabriela, G. C.; Geometri, E. T.; Eryvinka, L. S.; Utami, F. D. T.; Devana, E. M.; Aditama, L.; Kinasih, N. C. P.; Amadeus, V. C.; Hediningsih, Y.; Ananda, N. R.; Arguni, E.; Nuryastuti, T.; Wibawa, T.
title: Comparative analysis of the outcomes of COVID-19 between patients infected with SARS-CoV-2 Omicron and Delta variants: a retrospective cohort study
date: 2022-05-03
journal: nan
DOI: 10.1101/2022.04.30.22274532
sha: cb3a21e83cf31dbdfbdfe9bf3eb3f075e1f8f96e
doc_id: 746281
cord_uid: 9dm5j6gc

Background: The SARS-CoV-2 Omicron variant has replaced the previously dominant Delta variant because of high transmissibility. It is responsible for the current increase in the COVID-19 infectivity rate worldwide. However, studies on the impact of the Omicron variant on the severity of COVID-19 are still limited in developing countries. Here, we compared the outcomes of patients infected with SARS-CoV-2 Omicron and Delta variants and associated with prognostic factors, including age, sex, comorbidities, and smoking. Methods: We involved 352 patients, 139 with the Omicron variant and 213 with the Delta variant. The whole-genome sequences of SARS-CoV-2 were conducted using the Illumina MiSeq next-generation sequencer. Results: Ct value and mean age of COVID-19 patients were not significantly different between both groups (Delta: 20.35 +/- 4.07 vs. Omicron: 20.62 +/- 3.75; p=0.540; and Delta: 36.52 +/- 21.24 vs. Omicron: 39.10 +/- 21.24; p=0.266, respectively). Patients infected with Omicron and Delta variants showed similar hospitalization (p=0.433) and mortality rates (p=0.565). Multivariate analysis showed that older age ([≥]65 years) had higher risk for hospitalization (OR=3.67 [95% CI=1.22-10.94]; p=0.019) and fatalities (OR=3.93 [95% CI=1.35-11.42]; p=0.012). In addition, patients with cardiovascular disease had higher risk for hospitalization (OR=5.27 [95% CI=1.07-25.97]; p=0.041), whereas patients with diabetes revealed higher risk for fatalities (OR=9.39 [95% CI=3.30-26.72]; p=<0.001). Conclusions: Our study shows that patients infected with Omicron and Delta variants reveal similar clinical outcomes, including hospitalization and mortality. In addition, our findings further confirm that older age, cardiovascular disease, and diabetes are strong prognostic factors for the outcomes of COVID-19 patients.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 3, 2022 Conclusions: Our study shows that patients infected with Omicron and Delta variants reveal similar clinical outcomes, including hospitalization and mortality. In addition, our findings further confirm that older age, cardiovascular disease, and diabetes are strong prognostic factors for the outcomes of COVID-19 patients.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 3, 2022. ; https://doi.org/10.1101/2022.04.30.22274532 doi: medRxiv preprint

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the ongoing global pandemic of Coronavirus disease 2019 (COVID- 19) . As RNA viruses, SARS-CoV-2 is undergoing continuous mutation and evolution, giving rise to novel variants with the selective fitness advantage [1] . These variants have different characteristics due to their unique sets of mutations, including transmission rate, immune escape, and clinical severity. Variants with sufficient evidence of increased transmissibility, more severe diseases, or reduced vaccine or antiviral drug effectiveness have been designated a variant of concern (VOC). Therefore, these variants continuously impact both global health and the economy, with millions of people infected, hospitalized, and dead [2, 3] .

The Omicron variant (B.1.1.529) was first identified in a sample collected in Botswana on November 11, 2021 . However, it was first reported by South Africa on November 24, 2021.

Only within two days, the Omicron was classified as a variant of concern (VOC) by the World Health Organization on November 26, 2021 [4, 5] . In Indonesia, the surge of COVID-19 cases due to the Omicron variant occurred from late January until February 2022. Subsequently, the Omicron variant was found as the most frequently detected VOC compared to the previously dominating Delta variant [6]. SARS-CoV-2 genomic surveillance in Indonesia is continuously conducted to monitor circulating SARS-CoV-2 variants.

Because of high transmissibility, the SARS-CoV-2 Omicron variant has replaced the previous dominant variant, i.e., the Delta variant. It was responsible for the current increase in the COVID-19 infectivity rate worldwide, including in Indonesia [7] [8] [9] . However, studies on the impact of the Omicron variant on the clinical severity of COVID-19 are still limited in developed countries [10] [11] [12] . Several studies in developed countries showed a lower clinical severity of . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Omicron-infected patients than Delta-infected patients [10] [11] [12] . Several factors have been associated with the clinical severity of infection, including vaccination status and the previous SARS-CoV-2 infection. In addition, we and others have shown that several prognostic factors have been associated with the outcomes of COVID-19 [13] [14] [15] [16] [17] . Therefore, to further comprehend the impact of the Omicron wave in developing countries, we performed a comparative analysis of the outcomes of COVID-19 patients infected with Delta and Omicron variants and associated them with several prognostic factors, including age, sex, comorbidities, and smoking. Our study thus contributes to informing the public health response against the emerging SARS-CoV-2 variants.

We used data from 352 patients with COVID-19 from Yogyakarta and Central Java provinces, 

We collected all samples from nasopharyngeal swabs of outpatient or hospitalized patients with COVID-19 from May 2021 to February 2022. Subsequently, samples were sent to COVID-19 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) We conducted whole-genome sequencing (WGS) of SARS-CoV-2 for all samples with PCR's Ct value of less than 30. As described in our previous studies [13,14,18, using Burrow-Wheeler Aligner (BWA) algorithm embedded in UGENE v. 1.30 [20] .

A dataset of 392 available SARS-CoV-2 genomes was extracted from GISAID from our region and others (Acknowledgment Table is CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 3, 2022. ; https://doi.org/10.1101/2022.04.30.22274532 doi: medRxiv preprint multiple nucleotide sequence alignment was performed using the MAFFT program version 7 (https://mafft.cbrc.jp/alignment/server/). The neighbor-joining statistical method with 1,000 bootstrap replications [21, 22] was used to construct a phylogenetic tree from 29.409 nucleotide length of the open reading frame (ORF) of SARS-CoV-2, followed by computation of the evolutionary distances and model of the rate variation among sites by the Kimura 2-parameter method and the gamma distribution with estimated shape parameter (α) for the dataset, respectively [23] . The DAMBE version 7 [24] was utilized to calculate the estimation of the α gamma distribution, MEGA version 10 (MEGA X) [25] for phylogenetic reconstruction, and followed by tree visualization in FigTree (http://tree.bio.ed.ac.uk/software/FigTree/) to using a Newick tree output from MEGA X.

We associated the outcomes of COVID-19 patients with the following prognostic variables: sex;

age; comorbidities, including obesity, diabetes, hypertension, cardiovascular disease, and chronic kidney disease; and smoking. According to the previous reports, those prognostic factors were selected [13] [14] [15] [16] [17] .

The data were presented as mean ± SD and frequency (percentage). We determined the normality of the continuous variables by the Kolmogorov-Smirnov test. We excluded the missing or incomplete data from the final analysis. We used Chi-square or Fisher exact tests with a 95% confidence interval (CI) to find any significant association between variables and the outcomes of COVID-19 patients. Subsequently, we performed a multivariate analysis using a . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 3, 2022. 

Phylogenetic analysis showed that about 60.5% ( p=0.266, respectively) ( Table 1 ). All clinical characteristics of both groups were similar, except for the comorbidities of diabetes (p=0.022) and chronic kidney disease (p=0.019) ( Table 1) .

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 3, 2022. 

The hospitalization and mortality rates were not significantly different between patients infected with Omicron and Delta variants ( Table 2 ). The older patients were less hospitalized than the . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 3, 2022. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 3, 2022. [12] . Differences between our findings and previous reports might be affected by several variables, including host genetic background, public health measures, previous SARS-CoV-2 infections, and vaccination coverage [26-31,] . Unfortunately, incomplete data on . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 3, 2022. ; https://doi.org/10.1101/2022.04.30.22274532 doi: medRxiv preprint vaccination status and previous SARS-CoV-2 infections of our patients hampered us to analyze further the impact of both variables on hospitalization and mortality in our patient cohort. Up to April 16, 2022 , the vaccination coverage in Indonesia was 95.13% and 78.08% of the population for single and double doses, respectively [32] . In addition, the outcome of COVID-19 varies among the ethnic group [26] [27] [28] . Therefore, further study is essential to determine the association between host genetic risk alleles and the COVID-19 outcomes in our patients. Notably, while a previous study only analyzed patients admitted to the emergency department [12] , we comprehensively analyzed the patients both in the hospital and community.

Previous studies showed that older age and comorbidities are significant prognostic factors for hospitalization and mortality [13] [14] [15] 33, 34] . Our study further provides evidence that older age, diabetes, and cardiovascular diseases as strong prognostic factors for the outcomes of COVID-19 patients. A recent systematic review showed that 50%, 20%, and 10% of older patients with COVID-19 had a severe illness, critical illness and died, respectively [35] . Several variables had attributed to the worse outcomes of COVID-19 in older patients, including associated comorbidities and delayed diagnosis due to atypical clinical manifestations [35] .

Eighty percent of older patients with COVID-19 had a minimum of one comorbidity, such as hypertension, diabetes, and cardiovascular diseases [35] . Diabetes patients might have an uncontrolled immune response and increased ACE-2 receptors and furin during SARS-CoV-2 infection, while the use of antihypertension causes aberrant ACE-2 receptor expression in hypertension patients [36] . Both mechanisms lead to the severe illness of COVID-19 patients [36] . A recent report revealed that COVID-19 patients showed a higher risk of having cardiovascular diseases one month after acute infection [37] . They strongly suggest that the . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 3, 2022. ; https://doi.org/10.1101/2022.04.30.22274532 doi: medRxiv preprint survival patients should be closely followed-up for the cardiovascular diseases after acute COVID-19 infection [37] .

Children were more hospitalized during the Omicron surge than another variant surge [38] . The risk of hospitalization in children under four years during the Omicron surge was 5times higher than during the Delta surge, particularly infants <6 months old [39] . However, the COVID-19 severity was not affected by age [39] . It is suggested to vaccinate any eligible subjects, including pregnant woman, family members, and their caregivers, to prevent children <4 years from getting COVID-19 infection [39] . Interestingly, maternal antibodies developed following vaccination can undergo transplacental transfer. Indeed, younger children can receive protection [39] . Our study did not show any difference in hospitalization and mortality rates between children and adults. Moreover, we grouped all pediatric populations from neonates, infants, young and older children into one group, i.e., <18 years.

A previous study showed that the Ct value of Omicron was significantly higher than Delta, implying that higher transmission of Omicron does not necessarily associate with its viral load [40] . Their findings might be affected by the vaccination and prior infection of COVID-19 due to the vaccination coverage and infection rate being higher during the Omicron than the Delta surge [40] . However, our study found that the Ct value was not significantly different between Omicron and Delta variants.

Although the clinical outcome of Omicron is less severe than Delta, it should be noted that Omicron has higher transmissibility and immune escape from previous COVID-19 infection and vaccination. These findings caused an extraordinary surge of COVID-19 globally and might affect the healthcare systems, including high absolute numbers of hospital admission and . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 3, 2022. ; https://doi.org/10.1101/2022.04.30.22274532 doi: medRxiv preprint mortality rates [11] . Indeed, public health measures and vaccination are still crucial to control the COVID-19 spreading and decrease morbidity and mortality.

Several limitations are noted in our study including design of retrospective study, incomplete data on vaccination and previous infection of COVID-19, data were based on hospital admission, but no data from ICU admission unit and the use of mechanical ventilation, no follow-up data for patients after discharge from hospital, and incomparable sample size between Delta and Omicron variants.

Our study shows that patients infected with Omicron and Delta variants reveal similar outcomes, including hospitalization and mortality. In addition, our findings further confirm that older age, cardiovascular disease, and diabetes are the strong prognostic factors for the outcomes of patients with COVID-19.

All data generated or analyzed during this study are included in the submission. The sequence and metadata are shared through GISAID (www.gisaid.org).

This study was approved by the Medical and Health Research Ethics Committee, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr. Sardjito Hospital, Yogyakarta, Indonesia (KE/FK/0563/EC/2020). The research has been performed following the . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Pandu Biosains). We gratefully acknowledge the authors, the originating and submitting laboratories for their sequence and metadata shared through GISAID. We also thank Besar Besar . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Phylogenetic trees are displayed in rectangular (a) and polar (b) layouts. The evolutionary history was inferred using the Neighbor-Joining method [1] and computed using the Kimura 2-parameter [2] method with 1000 bootstrap replication in MEGA X [3, 4] . . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 3, 2022. ; https://doi.org/10.1101/2022.04.30.22274532 doi: medRxiv preprint

Jumping a Moving Train: SARS-CoV-2 Evolution in Real Time

World Health Organization

Coronavirus Pandemic (COVID-19) [Online Resource]. Our World in Data

World Health Organization, Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE). Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern

Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa

Accessed on

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic

Covid-19: Omicron drives weekly record high in global infections

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted

Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and Delta (B.1.617.2) variants in England: a cohort study

Clinical outcomes among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern California

Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments : A Retrospective Cohort Study

Is the Infection of the SARS-CoV-2 Delta Variant Associated With the Outcomes of COVID-19 Patients?

Association between prognostic factors and the outcomes of patients infected with SARS-CoV-2 harboring multiple spike protein mutations

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted

The effect of BMI on COVID-19 outcomes among older patients in South Korea: a nationwide retrospective cohort study

COVID-19 pathogenesis, prognostic factors, and treatment strategy: Urgent recommendations

Molecular epidemiology of SARS-CoV-2 isolated from COVID-19 family clusters

Full-length genome characterization and phylogenetic analysis of SARS-CoV-2 virus strains from Yogyakarta and Central Java

About UGENE -Unipro UGENE Online User Manual v. 1.30 -WIKI

The neighbor-joining method: A new method for reconstructing phylogenetic trees

Confidence limits on phylogenies: An approach using the bootstrap

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity

A simple method for estimating evolutionary rate of base substitutions through comparative studies of nucleotide sequences

New and improved tools for data analysis in molecular biology and evolution

Molecular Evolutionary Genetics Analysis across computing platforms

Evaluation of the genetic risk for COVID-19 outcomes in COPD and differences among worldwide populations

Genomewide Association Study of Severe Covid-19 with Respiratory Failure

COVID-19 and its Cardiac and Neurological Complications among Ontario Visible Minorities

The effectiveness of public health interventions against COVID-19: Lessons from the Singapore experience

Effective public health measures to mitigate the spread of COVID-19: a systematic review

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity

A country level analysis measuring the impact of government actions, country preparedness and socioeconomic factors on COVID-19 mortality and related health outcomes

Molecular Evolutionary Genetics Analysis across computing platforms

Outcomes of COVID-19 patients with comorbidities in southwest Nigeria

Clinical features and outcomes of COVID-19 in older adults: a systematic review and meta-analysis

COVID-19 and comorbidities: Deleterious impact on infected patients

Long-term cardiovascular outcomes of COVID-19

Does Omicron hit kids harder? Scientists are trying to find out

Hospitalization of Infants and Children Aged 0-4 Years with Laboratory

The authors declared no potential conflicts of interest concerning this article's research, authorship, and/or publication.

We thank the Collaborator Members of the Yogyakarta-Central Java COVID-19 study group: is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 3, 2022. ; https://doi.org/10.1101/2022.04.30.22274532 doi: medRxiv preprint It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 3, 2022. ; https://doi.org/10.1101/2022.04.30.22274532 doi: medRxiv preprint